Read more about What is Delta variant of Covid and how effective are vaccines against it? on Business Standard. Because of its rapid transmission not just in India but in several other countries, the WHO graduated it from a "variant of interest" (VOI) to a "variant of concern" (VOC)
Explained: The Delta Variant Of COVID-19 Virus That Caused 75 Per Cent Of Post-Vaccine Infections In Delhi
by Swarajya Staff - Jun 5, 2021 04:45 AM
Coronavirus (Representative Image)
Snapshot
Delta variant, or B.1.617.2, is the most pervasive variant of the novel Coronavirus in India as of now
A study by scientists at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) and the National Centre of Disease Control â two key labs of the Indian Sars Cov-2 Genomic Consortium (INSACOG) that tracks the emergence of key variants of the coronavirus â claims that novel Coronavirus variant âDeltaâ (B.1.617.2) caused three out of four âbreakthroughâ infections in Delhi.
A new study reveals that the Pfizer and AstraZeneca COVID-19 vaccines are very effective against the Indian variant of coronavirus. Read on to know more.
Updated:
May 19, 2021 08:39 IST
The B.1.617 virus variant, first identified in India last year, has been classified as a ‘variant of concern’ at the global level by the World Health Organisation.
Share Article
AAA
Vials labelled Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen in this illustration picture. File
| Photo Credit:
Reuters
The B.1.617 virus variant, first identified in India last year, has been classified as a ‘variant of concern’ at the global level by the World Health Organisation.
COVID-19 vaccines that are available in the United States are effective against the deadly variant that was first detected in India, top U.S. health officials said on Tuesday.